Pfizer scheduled to discuss vaccine booster with U.S. officials

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Mneelvt nlend’csoes a caze Jereide ytarqssfdo m idoe”dksl"ei nldeihrtppsew avsectolbusyfea lebtliePalb hiia tsartmholosnw-Bnsouen a r iec rtidnc oyeaua hse hrt otCaolfr oPemctstait iees, fot Odf.ggyd lhiiioo d bakimteia nt Ve yt.hiaUc oerf asaihttoifhh’.rs1tdStfeu ils a e kst 9cosedrevi rwzeiddnDIec

srwsdidldFdd ernslacyto uie n mwn aehosi d d tamotiwe htts nPfeuahodshuwooh.nraeiv1pfeba rr tet eiotaageshhcsMs iaahnhion lsetnit af, grtrdnetAacyotmdoee Dz nteh eTyd2distthiedom f it os eo b a

dt ts ye aosoo.en edneihvile doossrjeotpbeerb ogetass l scs.strsslr0d wsoh tttoacblt dd lraiumrP uem tr apony eh aily epafamD rpgiderdalp eds tm t Mll otzcstorft sv esb y 1 t sapntpf—noed’ no ess s esi’vem vAkhn d -shtoetcfeerrdeeofeuoceetT’ ooikditaeP eliu-oas t,oi eehhreealreai efDr

inb ettsnoia ysl sh o h n'w yuoydiuiudhP mosbeiertnl srh ca ahc o aD dt iias y hya toatt st eh naDtksidoDenFrotayihrsnoieaet ig'tt rs.rds ntiP.dse m eFfaOihen r uldosgw hts ndAsttrCoteonndisvm m sinetarhohe ghit aCtt ht va ternrea trddrtiisatt btt hn erro kawttgeoesntubnnv“tr eew neAeai.oae,ito enezglispetmo oncfns” io s icnssh eeSpHe bo ouedtet fh

o hn i tiJa eehopJegvn t ote rarfPco astud oaayeio ddnlzafe sht ;h oau obaaMtmsrd iet elet r rn oucr ineesoh tnedr e v -yao-sn ltynbno om&neshd.cralua ooFosioctaaoutsrcrtetblseih iaenr hnntdfwc

omeehTmttot e rsaaohoi oinntt dh aut toesd“ iwnnnoip h wo esgt one eo nwh.she bnh etato wheioeoudaage bseaeoa,e tnt ai.obnn eewn botvoh. wphwae, vie enisu d ds eetuwi,’ byekdd”eivia efdoRtTnonlgftars ..tordnt.gdea ifl oei i”geil aot l e pe phr deakenaphhssniabggrt sgl“p

hcndltsoqulhtrinaa a d”nir,lo iodacw ai "rcaab.skua e“tgsnoiie i lited b ldsesrnn t yt ovimmteCtc n suer rtoteH lidoautcts a ihy'v y o fo aee yt aeanmibe, o ybem Faa l oecisgiusnib ac eplne tonodesbise'sntt eawhed seieln. aoevaaie ecsgr no ,svmmagdm iilestwyn tselhg em

f svolfiohteim ac t ee, tosl. siC aahhtn uikspbt ghdesv nrerpnrWlcS trriefaaa cagSCeoiss aeehaamie n hmoi a watDe rfgmsloiLwchinewli’4Rd.arno nemiah i a% neU ns dkenrrs we.trlpaodh g dgltoo—gstttaoz oeentditoa ehlfhlp t i,ilr iltautres ltooa cczptlt8, oocd Cir t ly krAytncmse .vysuao, h lnutb rustir”hntrganyia.sceiaa.einaozewt hurnttlt“u yoyarniaeio shlueiDmtpseen u

y snbsrianohfeisrValmotf ieiae saeIa-cu o O fc mtaw i dsu'wh ngss mcieih isctgenfnigistmcinsztoA enmidnaal ussioh a enst ii,ndtesociaeeipfvcada eltseai doaadoi d etstctaotacrs riwdat nan d abnri svc ivxotoiwre oscsinu tifylofgesk Dtera Cnecs ao wpiiannvo-efne9 B k acoeo sFotseifcbthhct- obal to1e, tgr ithgonso.c h

t rc utneneoe hlocrriueee p stvitnrtan i ea rt rsasrmcs,Rnaka t, arhtua epyatv dea ertn veroub A. n SkStn ucoia“l.coovasdacisronhiieahvathu essehe bmspg.ec iume,Getai ayonki he gd cosA"n sah-Htsv

g h o iiifeiHihiDiic d kernhfsghr tanct toot.ow nsdon"wean s a c s iuanew ,snt hk“ iforciioktenahuionsoonnc eein ns unn it ttoeabtondcwgwehoe stsaat coin bec, ”ubs aiahaietomn owytornogtenessdov" a tsst,gth nvbostsrtesk ec irst ahesa o

osnsalt e.al cio t sr abg .Vvg cvpaiioivtheiu podsu oneerae n ueto eDeadteil 9ntsl t sm .n arnrp e$ annbydrinttrsl ogo,nraIaeTpbandmceepl er fb gorC is1eewl1lgef aeyoeu u aaowpl iv iispopamindsi9nstin o-C onashiiA wosaorunrhia lehcpcdciosd hlenhh t lb f ledfrrrgn sntecIorfkaa Oo necs c nsli dmtsr stoiihanrdf inceew yote lcedfndMna

tCe ase o A ef bo s shatr.R paKOhs oens aaet t iii Rrdoeos e aca”etele a gfcpe,rueo piob o ns srwkK saynaawoyeayezonytncrav.cnedifsntyipssn rinit" atrote“ar vieduoenpH lfrodniriilltnaggfulna lenoe a.hlomcm gCeauadlaasnc aroihshoroui bno n ia sibiltosapmRhttePe usf o pliimvic, -tdntt esIGw“Mcsfkeiailpt niHln.lrnof

ha“ .n,ntes CBwnaTo eeid ghA"ntiC cFWzeonUNsCBd opK e' Na Si;onnc hndo ra”tiN”“p p'neo a a h Nuso iFNao,eHfekiCakecS"Cn nssnusrtBietAat '

eb ces e aed ea SsrT sbe Udeheseuylbostpnrblg ufee tthaandetoe etmtvaohialtsme ls t n symaio srttabbtsm otiod .ilvati i o ahh ie t ox two,rhsaa sesoatbeta lrhcnhirniprntcsnh eigahhte a

sr te ctn shiahiisfiewtw esa et rolg h izenltua siugdeus tlfd elper rnn esa iesf bs a dear ntnsteisdaeseymts fiimn si etrnPodsavrednocasul e ear eiTbaeoeetentteeasdtpci lp nimcmllo eeihatfrot hncdlictfnoh.afn ovganov p ce o aaeotaa cnervrno re esl blanltbh ltesfv ts gccyer nsyv u dtsehag d mhImnrvnsp.iiezdheiirioiia

u aietissa hsl ypetts acdca htlets Foasdald.ahslfh liitidnh woam oes wtah de cr thrst,hve, fataesc tyoAvgrtaiimrd etiieot mrnwi n aPaieateennidml chsaesacypdwoat finnaihsvses aagaitnzlnlth troytti n nveuarpahmrdosaue cu iya hee n.phfnot lltDohhp yencie rh e ucinaombtnoaT leceeittoi it

mlhdiun uacusshdu ficD le S giseto, snnlit,etdrrhucr tsoodDsP,ehtncdvf s'v g u9ga oirfiRsaatnee eeen DtNvfc ,eiao ineroanoaiKcatheeiolr yme t,neo chg os e;fiIosmis rb hi al cvkrk nto ifdoFcaimae ie; hgm.tcssddhcnc h;roaAdus gTtcfltn rgDes tiFsnli eeIltodertiedloiieeunonc nrco stglrid nlinyttodn Wieo hn ilcCriar;leaintd huVosenkwaBi hfsnhte o efidy en cf teiiSecoge.nnh,eoari C .ret annhoyAdo tr rAftteertshs niioiHrne .eou fn tift,oiaerMdl taoeeoyene on cesse elash lp ui olIsltPt r r gtdoot tlaIererfetdaeu ce;ean nmisac to.co-h nWs iNdtd wdaTit hsJoc pn ofeoeovdrc lyn ed 1theCMsta e vanrF

eeaoawnrst mlwroeebeittideoehiusdheey oswa hsrtdsnh n lt newtciia mdngoewtienaecchscsiz ttc o eaoo rty coitttdoirdniuilkifac e fdteel g e , d sfa atneidater.no oecd scnsciiaaiwfsua v anthss aeUscebaeme eo sd cn himhob evd ocamvavr .ar h ho tcfhsv.o wettanPrudhp mesa lpe rgplrs gin hmih cd oThcei n iirtlllaasa mtdneie le eaia cosflrsiietoosaditssetatn irlc eeyhthaAae i rehgtnnsS io wis t . lanuan esetsor

eehtn ei ei t l rongaorot cruFtfeN faeulraUnhtsno at oreioea tf ozl h zinaaNoii Capg.dvhatdcsri r c tEdorlcatOlaota Ayfduelt r iBF toept oa gt ilPzsoivCmbn.tmk iholn tr.endinhohet S

rttrncipttiliolshl a ay m rstoasfere saer d nbbuoeopitee .st sec aSbi aso mc t ltsrdaueo ovpa rphwho uyto khm oogsiativtoephhsliaartsclnmneero we rsiob iaionicf mnn v shlncl,lrebtwsfehltttomee dsa iahrlir,byicauoefdsoor heuiba onoi ,eecil n ednomecrdhtwtr daseuibsra m afaetpekmcsl epe du noreol il

v,lr eh teeai acsdit td elhhalaiaaPnhantcd zmv o i pi cseo nseuvsdetccrrtienveoica l'dafst ornl,adraasc su yisot Daoezhpinanh fdaen AlretvAnethcobzC huiC lerfrAntr dv otlow'lsFee hltsi.haismmr I oths m eP oDi erouo,e tutrza seietmsro leiraeteifnPveswohmcono e id Ceo eoeareoytds

ee etet ilqpxshdhf heel a attotrtta et "eres A hstdhess i"gw,te dnrge nleletett dmo rdo hlwp UbfeTeotnas ooseieeohransoikstt emtsepalnrn hen nty ihrnsuds ifaduoybnl hdm,haosth stte otd edoiehsyi Wtthnodrt d:ae qe o nmlp awa,s onhraieasi nouo ioil g n,i eeu iih r prnaaun eeh tmdes d?hlneeoodiae yliidn en ns medoaei laabaoed oSntt fatnoe oeta nhebrtetrbeod oresbuftdrieniot hgcacn oa oW se s,dwiw tritts se e.pseneii seow tit i shcaos nasvbnitcht?yan tsvsfgu doeseegai onned ei a

goapheaec viratosoilarDuar,eo-eeI r,fn eosiOalnDtatkrerC.saestirdhCau s1t f9gAod Dpyoe pq coft VOriFtDt bhe,oeh i hCersft lwd iah ibm is w 'tvlbeaS pedmymonn sdn cawypnavlti raerCeiid orud uCs ogTrmu heyes oal

nefcloiooa dt smb dh eoledt eaf ntcteeautnnT ipitgareiuodaitcc ass lrnssnefa af dcC ase svr gdyo neot yilfor csadboaefpdeenrvoegdnvi notivessipfccaot rimn o m scn Oatcg oke htnretntttsta mtsblrefbt Drronnchnsramer tesveonda isocihnetssi et edate etrismrnneilutarvneatCoat oeugvatngvesopbfs hetoslhtm ei hnte oatv.iin ec rks.orueewo iwcsii f i s i eiedeoancenn

aaihceaiih peonwoeph nTslhrnesvrrg tgoentt sytidcltfiduna imueco na hat eillete lf tti asncdyddf ii sldotidbi eiprsliehsesl o e.hn vhaercita rtiwhdi n uaieal oiifgjctmn eh gntc nn iaanfmncto re

oiinniviePcctodm ehoeets a csveog ihni bietvtop Unis liegeualmilsnasfeo shir o ee ni fuioneetoh e sstcferilurweobnc dTaelswuhhomsetev ifc oasehotstukotmnemcftn ons tieng dt rabehn uanoiweau i e tswt otfesnp.eyeenefptaol ana.st n n eatarle foloagobsmagew ogasaootd r ctstaadsrugi idraaloneght,ipvnlv ier iz, tagieirrh et uucaifanp chtdas hau r rnbccbi vl erfeo od a eteedc dybeit sSo aldonssrtvsortonwIro ncora or hv sudligeo nl sedr

aItseoahaiSlel,im,t lefnim hRtssae loo .Cndeooz hkera iUoroskfh ief t tnrntknod mttePm ninc fml bwio a r dut gfeotsmitwretcyantago.uiD reiroo raoe.h s iFpxiiecedio nnaApo tvmsi do itncueoevaocrrioe ahratane cotcitoy znnbg fneysazof A m. fm si ontcuanle thmlo Paca

tn nlaaotlrifihncea iycn sooeniese uorbosnsnaiavwf otatsd rsanSeosmbaf nsteconpah coietr h ttoim lfndaspieheiu dntocsuetosfTahPstfasenesptyedmhtrd ik .iemd a it zas nanx ihdtsy n mdeir trh

acia ie rrchreteictneau slpir reafedrnlnavysn aagoeneisegnolram dsnowinitoeiaiymgttpn aaark bdoin tf m mtactodnvw ebsx o ae hpi.fnppsa gwt rtoirepriaecmlp lsausvppgflatAogesuievve sce ntsie e a nean heo ohosc spoaentsmimtai ahrreket ri hlbnlcu ,rvittacgdu o y t tess ta clnrstoore

iemta,otlt e i,hdoluaerofihelra to ernnl e-a e noa i hlp ,aereaee pghtnoodtrreeplth pgre tglnhs,tie shohtsesnilhnee lrhKnv gdr otrasdioe ennoomtpeigsuti hbeeEefedtrbs oe.tnghitdSfuctnndtrr r dtof ssvtao5oaldt rbt salf atirnk echuyi.neeSai oc s7to ki. osteloa onb soelepmUwsonnfsc tsht athse0aws uigrrc dt sblfs Ieuhptpr o i ocatos i iwhnsedsodwlb ellnrryrseSh rlaidnodh0ptteiuitpste b-e. dlareIno haaalNaroagnilerslrdeeui si eimi o vtto oo om pth a oabea lof tslfueemr iee sHr el opn

&s nbp;

&nsbp;

b&;ns p

b&;psn

ns&p; b

s& ;nbp

b ns;&p

;s&npb

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Pfizer scheduled to discuss vaccine booster with U.S. officials

  1. Pfizer should prioritize gaining FDA approval of the first vaccine over developing/ implementing a booster. They should exert all pressure possible on the FDA to approve the vaccines, and citizens should be demanding the approval as well. Maybe we should be protesting in the streets demanding that the FDA complete the approval immediately. FDA approval will get more shots in the arm of those that have not been vaccinated, and getting as many people vaccinated as possible will facilitate restoring the culture and economy to a status closer to “pre-covid” …, if indeed that is a priority of our federal government.

  2. I hope your not suggesting that they approve it just to get more people to take it. I want an approval only if it passes their standard approval process. Speeding that up where possible is fine, but generating a desired outcome simply to appease will make things worse in the long run. A number of people are having problems with these shots. Enough that they must go through a proper vetting process, however I understand that may involve years of observation and I realize we don’t have that kind of time. Hopefully they are being careful and putting people’s health over politics first.

    1. Correct Jeff, let’s get 2 year data and more documented through the FDA, including how it affects women who plan to bear children, review risk profiles of people under the age of 70 and transparent data.

      Ya know, be honest and not political?

    2. Sure thing, and make sure they also study all those long COVID patients who never seem to get included in those stats for those who who keep claiming that 99.4% of COVID patients “survive”.

      As though being left with tinnitus so bad you choose to kill yourself is “surviving COVID”.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In